Clinical Trials Directory

Trials / Completed

CompletedNCT06287580

Effects of Antihypertensive Drug Treatment on Brain Blood Flow, Cognition, and Regulation of Nervous System in Older Adults With Hypertension.

Antihypertensive Drug Effects on Cerebral Hemodynamics and Sympathetic Control in Older Hypertensive Patients

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
27 (actual)
Sponsor
University of Texas Southwestern Medical Center · Academic / Other
Sex
All
Age
60 Years – 85 Years
Healthy volunteers
Not accepted

Summary

High blood pressure (BP) is a public health problem worldwide. Nearly three-quarters of older adults (age \~60 years) in the United States have high BP. High BP links to many health problems, like stroke. Drug treatments are typically used in clinics to reduce high BP and the risk of associated health problems. However, these drug treatments may not always benefit brain health. For example, drug treatment may reduce brain blood flow, which may reduce cognitive function in older adults with high BP. Alternatively, reduced brain blood flow may cause high BP due to increased nervous system activity (the so-called "fight or flight response"). Thus, monitoring brain blood flow may help to manage high BP during drug treatment. It is unknown if brain blood flow and its control will be altered by drug treatment in older high BP patients. Therefore, study team will recruit older adults with high BP, who receive either drug treatment or a placebo for 1 to 2 weeks and will assess brain blood flow, cognitive function, and nervous system control before and after treatment. Results from this study will provide novel and clinically relevant information on the impact of drug treatment for high BP on brain health. Investigators expect these results will suggest that it is crucial to measure brain blood flow, which may be a therapeutic new target for BP control and brain health.

Conditions

Interventions

TypeNameDescription
DRUGchlorthalidonechlorthalidone, 12.5 mg or 25 mg orally once daily
OTHERPlaceboPlacebo tablet taken orally once daily

Timeline

Start date
2024-08-15
Primary completion
2026-02-20
Completion
2026-02-20
First posted
2024-03-01
Last updated
2026-02-27

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06287580. Inclusion in this directory is not an endorsement.